
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery Development and
₹4,430

Establishing Priorities: Volume II, Diseases of Importance in Developing Countries
by Institute of Medicine, Board on Population Health, Public He, Division of Health Promotion, Disease
Free delivery. Nothing extra to pay at checkout.
Common diseases cost the developing world an enormous amount in terms of human life, health, and productivity, as well as lost economic potential. New and effective vaccines could not only improve the quality of life for millions of residents in developing countries, they could also contribute substantially to further economic development.
Description supplied by the publisher.